Understanding the gut microbiome and HIV

Michael Dumiak

Why are HIV researchers interested in the bacterial and fungal environments present in the human digestive system?

Our bodies are not really ourselves: at least not completely.

Trillions of bacteria, fungus, and viral organisms make their homes throughout and on the surface of the human body in a series of mini ecosystems. Scientists refer to this as the human microbiome. The creatures that live in the microbiome are the microbiota.

Researchers are particularly interested in the microbiota and the composition of the microbiome in the intestinal tract in the stomach or gut. It is there that the microbiome seems particularly lively and where researchers suspect that altering or modulating the multitude of microorganisms that live there can have either ill or beneficial effects upon the health of an individual. One simple example of modulating the quantity of microorganisms in the gut is taking probiotics, such as those in yogurt, which are the types of good bacteria that can aid digestion. Viruses, like HIV, can have a negative impact on the gut microbiome, and there may be links between the gut microbiome and other diseases as well, including Malaria.

April 29, 2016
Year of publication
Resource types
Journal and research articles
HIV, digestive system, gut microbes, gut bacteria, microbiome, microbiota, intestinal tract, research

Similar Resources

Our previous result indicated that memory-like human natural killer (NK) cells from TB pleural fluid cells (PFCs) produced large amounts of IFN-γ in response to Bacille Calmette Guerin (BCG).

HIV eradication and remission research has largely taken place in high-income countries. In low- and middle-income countries (LMIC), there may be factors that have a substantial impact on the size of the latent HIV reservoir and the immunological response to infection.

Emphasis on adolescent HIV has increased worldwide as antiretroviral treatment has greatly extended life expectancies of HIV-positive children.

Efavirenz has become one of the most commonly used antiretroviral agents worldwide and is a component of WHO's recommended first-line antiretroviral therapy regimen.

Final follow up of the HPTN 052 study of treatment as prevention shows no evidence of HIV transmission from people with fully suppressed viral load to their partners, four years after the first results from the study demonstrated that early HIV treatment reduced the risk of HIV transmission by…

Starting antiretroviral therapy (ART) significantly reduces the risk of tuberculosis (TB) for patients in South Africa, investigators report in the online edition of AIDS.

A large proportion of HIV transmissions occur during recent infection or antiretroviral treatment interruptions, Swiss investigators report in Clinical Infectious Diseases.

All-cause 8-week mortality is reduced by rapid point-of-care urine-based testing for tuberculosis (TB), using a test for detection of mycobacterial lipoarabinomannan (LAM) to guide rapid treatment initiation in hospitalised HIV-positive people with signs and symptoms of TB, according to a late-…